44 filings
15-12G
AMAM
Ambrx Biopharma Inc.
18 Mar 24
Securities registration termination
2:45pm
8-K
AMAM
Ambrx Biopharma Inc.
12 Mar 24
Departure of Directors or Certain Officers
4:55pm
EFFECT
AMAM
Ambrx Biopharma Inc.
11 Mar 24
Notice of effectiveness
12:15am
S-8 POS
AMAM
Ambrx Biopharma Inc.
8 Mar 24
Registration of securities for employees (post-effective amendment)
1:39pm
S-8 POS
AMAM
Ambrx Biopharma Inc.
8 Mar 24
Registration of securities for employees (post-effective amendment)
1:34pm
S-8 POS
k1nihe
8 Mar 24
Registration of securities for employees (post-effective amendment)
1:29pm
S-8 POS
ydtp18
8 Mar 24
Registration of securities for employees (post-effective amendment)
1:24pm
S-8 POS
3e7ixb8hav82ffbg1in
8 Mar 24
Registration of securities for employees (post-effective amendment)
1:20pm
POS AM
pbut11
7 Mar 24
Prospectus update (post-effective amendment)
1:23pm
25-NSE/A
e9bx3z0q w7
7 Mar 24
Exchange delisting (amended)
9:46am
8-K
6urca5w
7 Mar 24
Termination of a Material Definitive Agreement
8:49am
8-K
e4suv8223ljx14e9f5
6 Mar 24
Ambrx Shareholders Approve Acquisition by Johnson & Johnson
4:05pm
DEFA14A
y8fa 29x6
23 Feb 24
Additional proxy soliciting materials
2:09pm
DEFA14A
dftpq6ahb 2h6mixu
22 Feb 24
Additional proxy soliciting materials
8:31am
8-K
jhkwozfbr kougjnl
22 Feb 24
Other Events
8:30am
DFAN14A
6pljmuuuhyih2
15 Feb 24
Additional proxy materials by non-management
5:23pm
DFAN14A
go15 5bqn2
29 Jan 24
Additional proxy materials by non-management
4:50pm
DEFM14A
p4e pw0zq8
29 Jan 24
Proxy related to merger
1:14pm
PREM14A
f9dkxx ldthvt
19 Jan 24
Preliminary proxy related to merger
5:26pm
DFAN14A
sy3cvot
9 Jan 24
Additional proxy materials by non-management
5:08pm